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INTRODUCTION
Dietary flavonoids have attracted much attention
because of their potentially beneficial effects in pre-
venting various diseases, especially coronary heart
disease. Quercetin is a major flavonol-type flavonoid
commonly found in vegetables and fruits, and in es-
pecially high amounts in onions. The bioavailability
of quercetin in humans has been studied by many
research groups (1). Quercetin metabolites have been
detected in human plasma as the glucuronide and/
or sulfate with or without additional methylation (2).
One of the major quercetin metabolites, quercetin
3-O-β-D-glucuronide, has been shown to protect low-
density lipoprotein (LDL) from copper ion-induced
oxidative damage in vitro (3). However, it is not
known whether quercetin metabolites present in hu-
man plasma following consumption of a flavonoid-
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rich diet can act as a part of biological antioxidant
system for protection of plasma LDL from harmful
oxidative stress.
We have previously reported that short-term in-
gestion of onions by female volunteers resulted in
accumulation of quercetin metabolites in the plasma
(4). However, these metabolites were only detected
in the LDL fraction at a very low level, and failed to
improve its resistance to copper ion-induced oxida-
tion following the trial. McAnlis, et al. (5) reported
that quercetin metabolites were not detected in the
LDL fraction after onion consumption by 5 healthy
volunteers and that no direct protective effect was
provided against LDL oxidation. On the other hand,
they detected quercetin metabolites in the HDL frac-
tion, although this fraction contained other proteins
including albumin.
The aim of this study was to clarify the distribu-
tion of plasma quercetin metabolites after single on-
ion consumption and to investigate their potential
antioxidative effect against LDL oxidation ex vivo.
MATERIALS AND METHODS
Chemicals
Quercetin-3-O-β-D -glucuronide (quercetin-3-glucu-
ronide) was chemically synthesized as previously
described (6). β-Glucuronidase H-5 (from Helix po-
matina) was obtained from Sigma Chemical Co.
(St. Louis, MO). Human serum albumin (essentially
fatty acid free), 2,2’-azobis(2-amidinopropane) dihy-
drochloride (AAPH) and 3-morpholinosydnonimine
hydrochloride (SIN-1) were purchased from Wako
Pure Chemical Ind. (Tokyo, Japan). All other chemi-
cals were of analytical grade.
Study design
Three healthy male volunteers aged 30-55 years
were recruited for this study. Each subject ingested
500 g of fried onions (Kagome Co., Japan), equiva-
lent to 150 mg quercetin aglycone, after fasting over-
night. Peripheral venous blood was collected into a
heparinized tube 0.5 h before and 1.5 h after con-
sumption. The protocol was approved by the Ethical
Committee of the University of Tokushima, Japan.
Isolation of lipoprotein fraction
Plasma was obtained from heparinized blood sam-
ples by centrifugation at 3,000 rpm for 10 min at 4.
To obtain lipoprotein fractions, plasma was further
subjected to density-gradient centrifugation. Briefly,
plasma was adjusted to d=1.21 with KBr and over-
laid with saline (d=1.008), and centrifugation was
performed at 600,000g for 40 min at 4. After col-
lecting the fractions containing VLDL/chylomicrons
(CM) and LDL, further centrifugation was performed
for 6 hr, and HDL was separated from the plasma
(the lipoprotein-eliminated plasma fraction). The pu-
rity of each lipoprotein fraction was confirmed by
SDS-PAGE (data not shown).
Analysis of plasma quercetin metabolites
Plasma and lipoprotein fractions were incubated
with 50 U of β-glucuronidase type H-5 (from H.
pomatia), which possesses both β-glucuronidase and
sulfatase activity, in 0.1 M sodium acetate buffer,
pH 5.0 for 60 min at 37. The liberated quercetin
aglycone was extracted with ethyl acetate. Quercetin
metabolites in the plasma and lipoprotein fractions
were determined using an amperometric detector-
HPLC system as previously described (4).
Binding of a quercetin conjugate to human serum
albumin
The binding study was performed as previously re-
ported by Janisch, et al. (7). Briefly, a human serum
albumin (essentially fatty acid free) solution (5 μM)
was mixed with quercetin-3-glucuronide (1.0 to 10.0
μM) and the tryptophan-derived fluorescence spec-
trum was measured (Ex 298 nm, Em 285-500 nm).
Antioxidant properties of the lipoprotein-eliminated
plasma fraction vs LDL oxidation
The LDL fraction isolated from fasting plasma
(0.2 mg protein/ml) was oxidized with the lipoprotein-
eliminated plasma fraction (2.0 mg protein/ml) ob-
tained from fasting and post-prandial plasma sam-
ples. AAPH was used as a pro-oxidant. The reaction
mixture was incubated at 37with continuous shak-
ing for 6 hr. To estimate the effect of quercetin me-
tabolites bound to plasma albumin, the lipoprotein-
eliminated fasting plasma fraction was incubated with
quercetin-3-glucuronide to mimic the albumin-bound
quercetin conjugates. Either CuSO4, AAPH or SIN-1
was added to this model solution and reacted simi-
larly. The time-dependent production of cholesteryl
ester hydroperoxide (CEOOH) was determined as
a marker of lipid peroxidation level, by UV-HPLC
analysis at 235 nm using an Octyl-80Ts (TSK-gel,
4.6150 mm, Tosoh) column and a mobile phase of
97% methanol at a flow rate of 1.0 ml/min.
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Statistics
Results are presented as meansSD (n=3). Sig-
nificant differences between values obtained under
fasting and post-prandial conditions were analyzed
by a paired t-test. Data were considered statistically
significant at p0.05.
RESULTS AND DISCUSSION
Plasma distribution of quercetin metabolites after
onion consumption in humans
Following onion consumption, the plasma concen-
tration of quercetin metabolites was significantly in-
creased compared to that under fasting conditions
(Table 1). On the other hand, the amount of quer-
cetin metabolites detected in the pellet or the red
blood cell fraction, was approximately 10% of the total
quercetin content in the blood and not different be-
fore and after onion consumption (0.1700.058 and
0.2140.040 pmol/mg protein, respectively). In the
plasma, 80% of quercetin metabolites remained in
the lipoprotein-eliminated plasma fraction (Table 1).
On the other hand, a relatively small proportion of
the quercetin metabolites were distributed in the
lipoprotein fractions. However, while these amounts
were increased in the LDL and HDL fractions after
onion consumption, the difference in content before
and after consumption was not statistically significant
because of the limited numbers of subjects (p=0.192
and 0.112, respectively).
Binding of a quercetin conjugate to human serum
albumin
As shown in Table 1, onion-derived quercetin me-
tabolites were exclusively localized in the lipoprotein-
eliminated plasma fraction. Albumin was the most
abundant protein in this fraction and quercetin me-
tabolites were considered to associate with serum
albumin. Thus, the binding ability of quercetin-3-
glucuronide, one of the major plasma metabolites, to
human serum albumin was examined by measuring
the quenching of fluorescence derived from trypto-
phan present in several binding subdomains (7). The
addition of quercetin-3-glucuronide to serum albumin
reduced the fluorescence intensity of the emission
maximum at 343 nm in a dose-dependent manner
(Fig. 1). These data are consistent with those pre-
viously reported (7). Thus, it is likely that plasma
quercetin metabolites are mostly bound to albumin.
Table 1 Plasma distribution of quercetin metabolites after onion consumption by human volunteers
Plasma
concentration
(μM)
CM/VLDL LDL HDL Lipoprotein-eliminatedplasma fraction
Upper : pmol/mg protein
(Lower : % of plasma)
Fasting 0.2630.042
143.790.7 18.812.5 8.744.50 2.971.55
(5.080.26) (3.600.76) (4.620.93) (79.71.94)
1.5 h after onion con-
sumption 1.0310.180
a
149.349.9 35.414.2 35.714.8 13.992.49a
(1.360.24) (2.200.68) (3.781.32) (83.93.25)
Values are meansSD, n=3. CM, chylomicrons ; VLDL, very low density lipoprotein ; LDL, low density lipoprotein ; HDL, high den-
sity lipoprotein. a P0.05 vs. Fasting.
Fig. 1 Effect of quercetin-3-glucuronide
on fluorescence quenching of human se-
rum albumin.
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Protective effect of albumin-bound quercetin me-
tabolites against LDL oxidation
Oxidized LDL plays a major role in the develop-
ment of atherosclerosis. Consumption of dietary an-
tioxidants, such as quercetin and other flavonoids,
is thought to prevent LDL from oxidative stress in
vivo. We previously reported that quercetin metabo-
lites inhibited LDL oxidation in vitro when incubated
directly with LDL (3). However, the quercetin me-
tabolites found in LDL after onion consumption were
not sufficient to protect LDL, because the suscepti-
bility of fasting and post-prandial LDL to oxidation
did not change (data not shown), consistent with pre-
vious reports (4, 5). The antioxidant capacity of quer-
cetin metabolites bound to albumin was next inves-
tigated. Fasting LDL was oxidized by the azo-radical
generator AAPH, in the presence of the lipoprotein-
eliminated plasma fractions from fasting and post-
prandial plasma. Onion-derived quercetin metabo-
lites present in the post-prandial plasma did not
show significant protective effects against AAPH-
induced lipid peroxidation (Fig. 2). In addition, when
copper ion was used as a pro-oxidant, no protective
effect emerged (data not shown). It has previously
been reported that albumin-bound quercetin con-
jugates exhibited a protective effect against copper
ion-induced LDL oxidation (7). Therefore, a possible
antioxidant effect of quercetin-3-glucuronide incu-
bated with the lipoprotein-eliminated plasma fraction
against LDL oxidation was examined. The quercetin-
3-glucuronide-bound albumin fraction inhibited LDL
oxidation induced by three different pro-oxidants,
AAPH, copper ion and SIN-1 (a peroxynitrite gen-
erator), in a dose-dependent manner (Fig. 3). In the
case of copper ion-induced oxidation, the low dose
of the quercetin conjugate enhanced LDL oxidation
(Fig. 3B). Janisch, et al. have suggested that bind-
ing of quercetin metabolites to albumin could re-
duce the chelating ability of the albumin molecule
(7). When AAPH was used as a pro-oxidant, the low-
est dose (100 pmol quercetin-3-glucuronide per mg
protein of albumin fraction) failed to protect LDL
from oxidation (Fig. 3A). This may explain why the
post-prandial albumin fraction did not prevent LDL
oxidation ex vivo in this case, because the plasma
concentration of quercetin metabolites after onion
consumption was relatively low (approx. 1 μM). From
these results and other previous reports (5, 7), it is
suggested that quercetin metabolites may accumu-
late in the plasma after consumption of a quercetin-
rich diet in the form of albumin-bound conjugates
and possibly play a role in plasma antioxidant ac-
tivity against LDL oxidation. However, since albu-
Fig. 2 Effect of the lipoprotein-eliminated plasma fraction on
AAPH-induced LDL oxidation. The lipoprotein-eliminated plasma
fraction was obtained either from fasting subjects or 1.5 hr after
onion consumption. The reaction mixture contained the lipoprotein-
eliminated plasma fraction and the fasting LDL fraction as a pro-
tein concentration ratio of 10 : 1. The concentration of AAPH used
was 0.5 mM. Values presented are the meansSD, n=3.
Fig. 3 Effect of free and albumin-bound quercetin-3-glucuronide on LDL oxidation. Oxidants used were 5 mM AAPH (A), 20 μM
CuSO4 (B), and 0.075 μM SIN-1 (C). The protein concentrations of the lipoprotein-eliminated plasma fraction (containing concen-
trated albumin) and LDL fraction used were 2.0 mg/ml and 0.2 mg/ml respectively, and final concentrations of quercetin-3-glucuronide
were 0.2, 2 and 20 μM. The results shown are representative. , control (without quercetin conjugate) ; , 0.2 μM quercetin conju-
gate ; , 2.0 μM quercetin conjugate ; , 20.0 μM quercetin conjugate.
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min itself is an effective antioxidant in the plasma,
the contribution of quercetin metabolites may be
rather insignificant. The significance of quercetin
metabolites bound to plasma albumin may not be
an involvement in plasma antioxidant defense but
may relate to a delay of their clearance from plasma,
thus allowing their efficient distribution to target
organs.
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